Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer.

Qinyu LiBingliang ChenGuoda SongKai ZengXin ChenJianping MiaoXianglin YuanJihong LiuZhihua Wang Zhihua Wang

Published in: Cancer cell international (2022)

The current study constructed a ceRNA network, AC005154.6/hsa-miR-29c-3p/CCNL2. Potentially, this biomarker can be used for early diagnosis and decision-making about prostate cancer treatment.

Keyphrases

prostate cancer
long non coding rna
cell proliferation
decision making
long noncoding rna
radical prostatectomy
wastewater treatment